Saturday, February, 23, 2019 02:41:36

OmniComm, Hitachi join forces to provide eClinical Solutions in Japan

Reports confirm that the leading provider of clinical data management technology, OmniComm Systems, Inc., has announced a partnership with pharmaceutical IT solutions firm Hitachi Inspharma. Apparently, under the terms of the partnership, both the companies would work together for providing eClinical solutions to life science …

IBM unveils AI-based fingernail sensor to track health and diseases

International Business Machines Corporation (IBM), a leading American multinational IT (Information Technology) company, has made it to the headlines for developing an innovative ‘Fingernail Sensor’ prototype. Apparently, the sensor employs AI (Artificial Intelligence) and Machine Learning for monitoring and analyzing human health and disease progression. …

Vedanta Biosciences raises $27M for microbiome-derived products

 The $27 million were raised in a Series-C financing with investors like Bristol-Myers Squibb and Bill & Melinda Gates Foundation participating in the round.  The money would be utilized to advance the company’s microbiome-derived product candidates. Vedanta Biosciences, Inc. (Vedanta), a renowned PureTech Health affiliate, …

Voluntis & AbbVie team up to develop companion digital therapeutics

Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …

Aduro Biotech & Lilly to collaborate for R&D of novel immunotherapies

The U.S.-based global pharmaceutical firm Eli Lilly & Company, and California-based immunotherapy company, Aduro Biotech, are currently in the news for announcing a research collaboration, as well as an exclusive license deal, for the cGAS-STING pathway inhibitor program that would develop new immunotherapies for inflammatory …